Brain Tumours in Dogs: Welfare-Centred Management

Brain tumours are among the most devastating conditions affecting dogs, causing progressive neurological deterioration. Welfare-centred management balances treatment options against quality of life.

Key Facts

Meningiomas are the most common primary brain tumour in dogs, accounting for over 50% of cases
Breeds with elevated risk include boxers, Boston terriers, and brachycephalic breeds for meningiomas
Clinical signs depend on tumour location and include seizures, behaviour change, blindness, and ataxia
Surgery, radiation therapy, and palliative treatment are the three main management options

Welfare Considerations

Brain tumour management presents acute welfare dilemmas. Surgery carries significant perioperative risk but can provide months to years of good quality life for meningiomas. Radiation therapy extends survival but requires multiple anaesthetic events. Palliative management with corticosteroids and anti-epileptics can maintain acceptable quality of life for weeks to months. Welfare assessment must account for neurological pain, seizure burden, and cognitive changes. Proactive euthanasia planning to prevent prolonged suffering is an important component of welfare-positive care.

What You Can Do

Seek specialist neurology referral promptly when brain tumour is suspected based on neurological signs
Discuss all treatment options including expected welfare impacts and duration of effect with your specialist
Use validated quality-of-life tools to monitor wellbeing during treatment and make timely decisions
Ensure adequate seizure control and pain management regardless of the primary treatment approach chosen